Skip to content
10-Q

Quarterly Report

Chinook Therapeutics, Inc.

0001564590-22-028434

← back to feed
Filed
Aug 8, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Jul 31, 2022 62.9M sh
Current Liabilities Q2 2022 · Jun 30, 2022 $29.48M
Current Liabilities Q2 2022 · Dec 31, 2021 $40.09M
Total Liabilities Q2 2022 · Jun 30, 2022 $94.11M
Total Liabilities Q2 2022 · Dec 31, 2021 $110.16M
Current Assets Q2 2022 · Jun 30, 2022 $371.4M
Current Assets Q2 2022 · Dec 31, 2021 $300.64M
Total Assets Q2 2022 · Jun 30, 2022 $601.24M
Total Assets Q2 2022 · Dec 31, 2021 $563.8M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $181.72M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $135.47M
Shares Diluted Q2 2022 · Jun 30, 2021 43.86M sh
Shares Diluted Q2 2022 · Jun 30, 2021 43M sh
Capex Q2 2022 · Jun 30, 2021 $744K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$55.51M
Stockholders Equity Q2 2022 · Jun 30, 2021 $296.73M
Stockholders Equity Q2 2022 · Mar 31, 2021 $300.52M
Stockholders Equity Q2 2022 · Dec 31, 2020 $334.62M
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.97
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.86
Eps Basic Q2 2022 · Jun 30, 2021 −$0.97
Eps Basic Q2 2022 · Jun 30, 2021 −$1.86
Sga Expense Q2 2022 · Jun 30, 2021 $7.77M
Sga Expense Q2 2022 · Jun 30, 2021 $17.31M
Rd Expense Q2 2022 · Jun 30, 2021 $22.79M
Rd Expense Q2 2022 · Jun 30, 2021 $48.48M
Net Income Q2 2022 · Jun 30, 2021 −$42.57M
Net Income Q2 2022 · Jun 30, 2021 −$79.79M
Net Income Q2 2022 · Mar 31, 2021 −$37.22M
Operating Income Q2 2022 · Jun 30, 2021 −$43.27M
Operating Income Q2 2022 · Jun 30, 2021 −$80.42M
Revenue Q2 2022 · Jun 30, 2021 $34K
Revenue Q2 2022 · Jun 30, 2021 $385K